Concepedia

James R. Piper

JR

Statistics

Publications

43

Citations

1.5K

H-Index

23

Active since

1963

Affiliations

Southern Research Institute(Current)

Memorial Sloan Kettering Cancer Center

SRI International

James R. Piper is an author at Southern Research Institute specializing in pharmacology, medicinal chemistry, and enzyme inhibition.

Publications per year

1963–2002

43

Publications

43

Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate.

Timothy D. Heath, Jane Montgomery, James R. Piper et al. · Proceedings of the National Academy of Sciences · 1983 · 109 citations · Full text

, , +17

Syntheses and antifolate activity of 5-methyl-5-deaza analogs of aminopterin, methotrexate, folic acid, and N10-methylfolic acid

James R. Piper, G. S. MCCALEB, Jane Montgomery et al. · Journal of Medicinal Chemistry · 1986 · 105 citations · Full text

, , +6

A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice

Francis M. Sirotnak, Joseph I. DeGraw, William T. Colwell et al. · Cancer Chemotherapy and Pharmacology · 1998 · 92 citations

, , +6

Antimycobacterial Activities of 2,4-Diamino-5-Deazapteridine Derivatives and Effects on Mycobacterial Dihydrofolate Reductase

William J. Suling, Lainne E. Seitz, Vibha Pathak et al. · Antimicrobial Agents and Chemotherapy · 2000 · 73 citations

, , +14

S-[2-(.omega.-Aminoalkylamino)ethyl] dihydrogen phosphorothioates and related compounds as potential antiradiation agents

James R. Piper, Carl R. Stringfellow, Robert D. Elliott et al. · Journal of Medicinal Chemistry · 1969 · 68 citations

, , +5

1–5 of 43